Procter & Gamble (PG) R&D chief exercises options and sells 15,169 shares
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Procter & Gamble's Chief Research, Development & Innovation Officer, Aguilar Moses Victor Javier, exercised stock options and sold shares on February 13, 2026. He exercised 15,169 stock options at an exercise price of $91.07 per share, receiving the same number of common shares.
On the same day, he sold 15,169 common shares in an open-market transaction at a weighted average price of $162.2789 per share, within a price range of $162.26 to $162.311. Following these transactions, he held 44,735.4826 common shares directly, plus additional indirect holdings through a retirement plan and an international stock ownership plan.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Seller: 15,169 shares ($2,461,609)
Net Sell
5 txns
Insider
Aguilar Moses Victor Javier
Role
Chf Rsch, Dev & Innov Officer
Sold
15,169 shs ($2.46M)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) | 15,169 | $0.00 | -- |
| Exercise | Common Stock | 15,169 | $91.07 | $1.38M |
| Sale | Common Stock | 15,169 | $162.2789 | $2.46M |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Stock Option (Right to Buy) — 0 shares (Direct);
Common Stock — 59,904.483 shares (Direct);
Common Stock — 6,870.27 shares (Indirect, By Retirement Plan Trustee)
Footnotes (1)
- Weighted average price of the shares sold. The price range was $162.26 to $162.311. Full information regarding the number of shares sold at each separate price available upon request. Reflects adjustment to PST through December 31, 2025.
FAQ
What did Procter & Gamble (PG) executive Aguilar Moses do in this Form 4?
Aguilar Moses exercised stock options and sold the resulting shares. He converted 15,169 options into common stock, then sold 15,169 shares in an open-market transaction, leaving him with a direct ownership of 44,735.4826 Procter & Gamble common shares afterward.
What stock options did Aguilar Moses exercise in this Procter & Gamble (PG) filing?
He exercised a stock option for 15,169 Procter & Gamble shares at an exercise price of $91.07 per share. The option was originally granted on February 28, 2020 and carried an expiration date of February 26, 2027, according to the derivative securities table.
What role does Aguilar Moses hold at Procter & Gamble (PG) according to this Form 4?
He is identified as an officer of Procter & Gamble, serving as Chief Research, Development & Innovation Officer. The Form 4 box for officer is checked, and his specific title is listed in the relationship section of the filing’s header information.
How is the sale price described in Aguilar Moses’s Procter & Gamble (PG) Form 4?
The filing reports a weighted average sale price of $162.2789 per share. A footnote explains that individual trades occurred between $162.26 and $162.311, and that detailed information on the exact share counts at each price level is available upon request.